EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer

John M Bryant, Luis Ruffolo, Kevin Soares, Sarah Hoffe, Andrew M Lowy

Journal of Clinical Investigation · 15.07.2025 · 135 (14)

DOI: 10.1172/jci191944 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.07.2025. Verfasst von John M Bryant und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Section of Gastrointestinal Radiation Oncology, Moffitt Cancer Center, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neoadjuvant Therapy, Carcinoma, Pancreatic Ductal, Cancer Vaccines. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in multidisciplinary oncology care, curing patients diagnosed with pancreatic duct adenocarcinoma (PDAC) remains all too uncommon. In this Review, we discuss evolving concepts to guide the care of patients with operable PDAC, focusing on adjuvant and neoadjuvant systemic therapies, the ever-controversial topic of radiation therapy, and the emerging role of cancer vaccines. Given the promise of biomarkers to better predict therapeutic response, the development of KRAS inhibitors, our ability to deliver higher doses of radiation therapy more precisely and safely, and the technology to rapidly produce highly personalized cancer vaccines, there is reason to expect that the guidelines for the care of our patients with operable PDAC will change rapidly in the next few years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeoadjuvant TherapyCarcinoma, Pancreatic DuctalCancer VaccinesHumansChemotherapy, Adjuvant

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Department of Radiation Oncology, Section of Gastrointestinal Radiation Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Department of Surgery, Hepatopancreatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Surgery, Division of Surgical Oncology, Moores Cancer Center, University of California San Diego, La Jolla, California, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Bryant, J. M., Ruffolo, L., Soares, K., Hoffe, S., & Lowy, A. M. (2025). Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer. Journal of Clinical Investigation, 135(14). https://doi.org/10.1172/jci191944

Vancouver

Bryant JM, Ruffolo L, Soares K, Hoffe S, Lowy AM. Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer. Journal of Clinical Investigation. 2025;135(14). doi:10.1172/jci191944

BibTeX
@article{Bryant2025,
  author = {Bryant, John M and Ruffolo, Luis and Soares, Kevin and Hoffe, Sarah and Lowy, Andrew M},
  title = {Evolving concepts in adjuvant/neoadjuvant therapy for resectable pancreas cancer},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  volume = {135},
  number = {14},
  doi = {10.1172/jci191944}
}
Kostenlos starten →